Assembly Biosciences, Inc. (ASMB): Depreciation & Amortization
$129.0K
Year ended 2025-12-31
$110.0K
Trailing 12 months to 2026-06-30
-36.3%
3-year compound annual growth
-28.5%
5-year compound annual growth
| Period ended | Depreciation & Amortization | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $129.0K | 0.0% | 2026-03-19, From 2025-01-01 |
| 2024-12-31 | $129.0K | -71.3% | 2026-03-19, From 2024-01-01 |
| 2023-12-31 | $450.0K | -9.6% | 2025-03-20, From 2023-01-01 |
| 2022-12-31 | $498.0K | +6.9% | 2024-03-28, From 2022-01-01 |
| 2021-12-31 | $466.0K | -32.6% | 2023-03-22, From 2021-01-01 |
| 2020-12-31 | $691.0K | +39.9% | 2022-03-11, From 2020-01-01 |
| 2019-12-31 | $494.0K | -23.2% | 2021-02-25, From 2019-01-01 |
| 2018-12-31 | $643.0K | +193.6% | 2021-02-25, From 2018-01-01 |
| 2017-12-31 | $219.0K | n/a | 2020-03-04, From 2017-01-01 |
Depreciation & Amortization at similar companies
| Company | Year ended | Depreciation & Amortization | Change YoY |
|---|---|---|---|
| Assembly Biosciences, Inc. (ASMB) | 2025-12-31 | $129.0K | 0.0% |
| Bicycle Therapeutics PLC (BCYC) | 2025-12-31 | $6.42M | -10.5% |
| Viridian Therapeutics, Inc. (VRDN) | 2025-12-31 | $460.0K | -14.8% |
| Rockwell Medical, Inc. (RMTI) | 2025-12-31 | $2.19M | +0.6% |
| Spero Therapeutics, Inc. (SPRO) | 2025-12-31 | $0 | -100.0% |
| Eton Pharmaceuticals, Inc. (ETON) | 2025-12-31 | $4.04M | +252.9% |
| Enanta Pharmaceuticals Inc (ENTA) | 2025-09-30 | $4.59M | +96.3% |
| Arcturus Therapeutics Holdings Inc. (ARCT) | 2025-12-31 | $3.02M | -14.6% |
| Nuvation Bio Inc. (NUVB) | 2025-12-31 | $1.74M | +154.6% |
Compare ASMB, BCYC, VRDN, RMTI side by side · Screen every company in Pharmaceutical Preparations ↗